EVERGREEN CAPITAL MANAGEMENT LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1260824
Bellevue, WA
Position in REGN
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$11,074,693
+$960,836 QoQ
Shares Held
17,761
+35.7% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#281
of 1,328 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 94%
Shared 4%
None 2%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026EVERGREEN CAPITAL MANAGEMENT LLC holds $27,458,740 across 28 Biotechnology names. REGN ranks #1 (40.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
17,761 | $11,074,693 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,222 | $2,097,194 | |
| 3 | ARGX |
Argenx SE
|
1,836 | $1,703,385 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
22,421 | $1,282,929 | |
| 5 | 8,952 | $1,105,572 | |||
| 6 | EXEL |
Exelixis, Inc.
|
15,411 | $838,512 | |
| 7 | RPRX |
Royalty Pharma plc
|
14,344 | $804,267 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
9,014 | $783,767 |
All Filings in REGN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,074,693 | 17,761 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $10,113,857 | 13,090 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,786,365 | 6,201 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $3,325,264 | 5,914 | Shares | Other | 2025-10-28 | |
| 2025-06-30 | $4,270,350 | 8,134 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,461,445 | 3,881 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $2,753,154 | 3,865 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $877,785 | 835 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $3,883,555 | 3,695 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $3,503,463 | 3,640 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $4,330,847 | 4,931 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $4,133,727 | 5,023 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,111,693 | 7,114 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $5,773,875 | 7,027 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $5,087,947 | 7,052 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,908,887 | 7,126 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $4,282,145 | 7,244 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,154,064 | 4,516 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,810,264 | 4,450 | Shares | Sole | 2022-03-11 | |
| 2021-09-30 | $2,428,587 | 4,013 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,980,927 | 5,337 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,468,844 | 5,218 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||